• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24117 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     NIHR Health Technology Assessment programme Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation
2017     NIHR Health Technology Assessment programme Facet joint injections for people with persistent non-specific low back pain (Facet Injection Study): a feasibility study for a randomised controlled trial
2023     NIHR Health Technology Assessment programme Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit–risk assessment: the BRAINS study including expert workshop
1998     NIHR Health Technology Assessment programme A cost-utility analysis of interferon beta for multiple sclerosis
2005     NIHR Health Technology Assessment programme Scottish trial of arthroplasty or reduction for subcapital fractures (STARS)- primary research
2003     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review
2005     NIHR Health Technology Assessment programme Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation
2006     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy: a systematic review
2017     NIHR Health Technology Assessment programme A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent (The FACS Trial)
2010     NIHR Health Technology Assessment programme A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin
2014     NIHR Health Technology Assessment programme Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation
2015     NIHR Health Technology Assessment programme Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness
2023     NIHR Health Technology Assessment programme Pragmatic randomised controlled trial of guided self-help versus individual cognitive behavioural therapy with a trauma focus for post-traumatic stress disorder (RAPID)
1998     NIHR Health Technology Assessment programme Cost-effectiveness of interferon beta for multiple sclerosis: the implications of new information on clinical effectiveness
1995     NIHR Health Technology Assessment programme Translation of Spanish report on routine pre-operative testing
2003     NIHR Health Technology Assessment programme Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system
2006     NIHR Health Technology Assessment programme Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling
2012     NIHR Health Technology Assessment programme Adapting health promotion interventions to meet the needs of ethnic minority groups: mixed-methods evidence synthesis
2013     NIHR Health Technology Assessment programme Randomised Assessment of Treatment using Panel Assay of Cardiac markers - Contemporary Biomarker Evaluation (RATPAC CBE)
2012     NIHR Health Technology Assessment programme Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development
2014     NIHR Health Technology Assessment programme Abiraterone acetate for the treatment of chemotherapy naive metastatic castration-resistant prostate cancer (ID503)
2016     NIHR Health Technology Assessment programme Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme
1999     NIHR Health Technology Assessment programme A systematic literature review of spiral and electron beam computed tomography: with particular reference to clinical applications in hepatic lesions, pulmonary embolus and coronary artery disease
2004     NIHR Health Technology Assessment programme A randomised controlled trial of intensive physiotherapy vs a home-based exercise treatment programme in knee osteoarthritis - primary research
2003     NIHR Health Technology Assessment programme Systematic review and economic decision modelling for the prevention and treatment of influenza A and B
2006     NIHR Health Technology Assessment programme Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation
2014     NIHR Health Technology Assessment programme Death, Bereavement and randomised controlled trials (BRACELET): a methodological study of policy and practice in neonatal and paediatric intensive care trials
2013     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: Assessment of Nausea in Chemotherapy Research (ANCHoR), a randomised controlled trial
2023     NIHR Health Technology Assessment programme One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT
2024     NIHR Health Technology Assessment programme Strategies for older people living in care homes to prevent urinary tract infection: the StOP UTI realist synthesis
1999     NIHR Health Technology Assessment programme What role for statins? A review and economic model
2005     NIHR Health Technology Assessment programme Developing evidence-based guidelines for the prevention of venous thromboembolism in surgical patients- systematic review
2003     NIHR Health Technology Assessment programme A randomised controlled trial to evaluate the clinical and cost-effectiveness of Hickman line insertions in adult cancer patients by nurses
2012     NIHR Health Technology Assessment programme Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer
1999     NIHR Health Technology Assessment programme Factors that limit the quality, number and progress of randomised controlled trials: a review
2007     NIHR Health Technology Assessment programme Efficacy and cost effectiveness of physiotherapy for children less than three years old with cerebral palsy - systematic review
2013     NIHR Health Technology Assessment programme Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation
2009     NIHR Health Technology Assessment programme Erlotinib for the treatment of relapsed non-small cell lung cancer
1999     NIHR Health Technology Assessment programme Antimicrobial prophylaxis in total hip replacement: a systematic review
2003     NIHR Health Technology Assessment programme Evaluation of molecular prenatal diagnosis for Downs syndrome- systematic review
2013     NIHR Health Technology Assessment programme Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review
2013     NIHR Health Technology Assessment programme Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model
2014     NIHR Health Technology Assessment programme Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey
2016     NIHR Health Technology Assessment programme Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): a randomised controlled trial with cost-effectiveness analysis
1999     NIHR Health Technology Assessment programme Health promoting schools and health promotion in schools: two systematic reviews
2003     NIHR Health Technology Assessment programme Preliminary economic evaluation of health technologies: methods and case studies - primary research
2004     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation
2012     NIHR Health Technology Assessment programme Management of frozen shoulder: a systematic review and cost-effectiveness analysis
2011     NIHR Health Technology Assessment programme Ranibizumab for the treatment of diabetic macular oedema
2014     NIHR Health Technology Assessment programme The clinical effectiveness, cost-effectiveness and acceptability of community-based interventions aimed at improving or maintaining quality of life in children of parents with serious mental illness: a systematic review
2016     NIHR Health Technology Assessment programme The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection
2005     NIHR Health Technology Assessment programme The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis
2004     NIHR Health Technology Assessment programme Routine examination of the newborn: the EMREN study. Evaluation of an extension of the midwife role including a randomised controlled trial of appropriately trained midwives and paediatric senior house officers
2007     NIHR Health Technology Assessment programme A systematic review of rapid diagnostic tests for the detection of tuberculosis infection
2012     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders
2012     NIHR Health Technology Assessment programme Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses
2015     NIHR Health Technology Assessment programme Double-blind randomised controlled trial of percutaneous tibial nerve stimulation versus sham electrical stimulation in the treatment of faecal incontinence: CONtrol of Faecal Incontinence using Distal NeuromodulaTion (the CONFIDeNT trial)
2022     NIHR Health Technology Assessment programme Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT
2024     NIHR Health Technology Assessment programme Cervical ripening at home or in hospital during induction of labour: the CHOICE prospective cohort study, process evaluation and economic analysis
2004     NIHR Health Technology Assessment programme Towards efficient guidelines: 1. When to develop guidelines- systematic review
2006     NIHR Health Technology Assessment programme Infrastructure for guideline development
2013     NIHR Health Technology Assessment programme Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis
2024     NIHR Health Technology Assessment programme The effect of two speech and language approaches on speech problems in people with Parkinson’s disease: the PD COMM RCT
2014     NIHR Health Technology Assessment programme A randomised controlled trial of the clinical effectiveness and cost-effectiveness of different knee prostheses: the Knee Arthroplasty Trial (KAT)
2013     NIHR Health Technology Assessment programme A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE)
2012     NIHR Health Technology Assessment programme Abatacept for the treatment of rheumatoid arthritis after the failure of conventional disease-modifying antirheumatic drugs
2021     NIHR Health Technology Assessment programme Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT
2021     NIHR Health Technology Assessment programme Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis
2007     NIHR Health Technology Assessment programme A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs The SANAD trial
2001     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review
2014     NIHR Health Technology Assessment programme A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care: the CHiP randomised controlled trial
2010     NIHR Health Technology Assessment programme Systematic review of the links between human resource management practices and performance
2017     NIHR Health Technology Assessment programme Debt Counselling for Depression in Primary Care: an adaptive randomised controlled pilot trial (DeCoDer study)
2020     NIHR Health Technology Assessment programme Surgical treatments compared with early structured physiotherapy in secondary care for adults with primary frozen shoulder: the UK FROST three-arm RCT
2016     NIHR Health Technology Assessment programme OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
2022     NIHR Health Technology Assessment programme Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling
2024     NIHR Health Technology Assessment programme Energetic activity for depression in young people aged 13–17 years: the READY feasibility RCT
2004     NIHR Health Technology Assessment programme Diagnosis of endometrial abnormality: comparison of outpatient procedures within cohorts defined by age and menopausal status
2002     NIHR Health Technology Assessment programme Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment
2013     NIHR Health Technology Assessment programme Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study
2013     NIHR Health Technology Assessment programme Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome
2014     NIHR Health Technology Assessment programme Imatinib for the adjuvant treatment of gastrointestinal stromal tumours
2019     NIHR Health Technology Assessment programme Platelet Rich Plasma (PRP) in Achilles Tendon Rupture (ATR) healing
2016     NIHR Health Technology Assessment programme Improving outcomes for people in mental health crisis: a rapid synthesis of the evidence for available models of care
2017     NIHR Health Technology Assessment programme A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial
2025     NIHR Health Technology Assessment programme A personalised health intervention to maintain independence in older people with mild frailty: a process evaluation within the HomeHealth RCT
2001     NIHR Health Technology Assessment programme Systematic reviews of (i) comparative studies of depot neuroleptic drugs, and (ii) studies of oral vs depot neuroleptic agents for patients with schizophrenia: clinical, social and economic outcomes- systematic review
2002     NIHR Health Technology Assessment programme Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation
2013     NIHR Health Technology Assessment programme Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive candida infection: the Fungal Infection Risk Evaluation (FIRE) study
2019     NIHR Health Technology Assessment programme Models Of Reablement Evaluation: a mixed methods evaluation of a complex intervention (The MORE project)
2017     NIHR Health Technology Assessment programme Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project
2024     NIHR Health Technology Assessment programme Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT
2025     NIHR Health Technology Assessment programme Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis
2010     NIHR Health Technology Assessment programme Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial
2002     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment
2010     NIHR Health Technology Assessment programme INTERVAL Dental recalls trial (Investigation of NICE Technologies for Enabling Risk-Variable-Adjusted-Length Dental Recalls Trial) - a feasibility study and follow on
2020     NIHR Health Technology Assessment programme A multicentre randomised trial to establish the effect(s) of routine administration of fluoxetine in patients with a recent stroke (FOCUS)
2017     NIHR Health Technology Assessment programme Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation
2024     NIHR Health Technology Assessment programme Devices for remote continuous monitoring of people with Parkinson’s disease: a systematic review and cost-effectiveness analysis
2006     NIHR Health Technology Assessment programme Evaluation of molecular techniques in prediction and diagnosis of CMV disease in immunocompromised individuals- primary research